KEGG   Homo sapiens (human): 10568
Entry
10568             CDS       T01001                                 
Symbol
SLC34A2, NAPI-3B, NAPI-IIb, NPTIIb, NaPi2b, PULAM
Name
(RefSeq) solute carrier family 34 member 2
  KO
K14683  solute carrier family 34 (sodium-dependent phosphate cotransporter)
Organism
hsa  Homo sapiens (human)
Pathway
hsa04928  Parathyroid hormone synthesis, secretion and action
hsa04978  Mineral absorption
Network
nt06325  Hormone/cytokine signaling
  Element
N01824  SGK1-NHERF1+NPT signaling pathway
Disease
H01298  Pulmonary alveolar microlithiasis
Drug target
Lifastuzumab: D11237
Lifastuzumab vedotin: D11238
Brite
KEGG Orthology (KO) [BR:hsa00001]
 09150 Organismal Systems
  09152 Endocrine system
   04928 Parathyroid hormone synthesis, secretion and action
    10568 (SLC34A2)
  09154 Digestive system
   04978 Mineral absorption
    10568 (SLC34A2)
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   02000 Transporters [BR:hsa02000]
    10568 (SLC34A2)
   04147 Exosome [BR:hsa04147]
    10568 (SLC34A2)
Transporters [BR:hsa02000]
 Solute carrier family (SLC)
  SLC34: Type II Na+-phosphate cotransporter
   10568 (SLC34A2)
Exosome [BR:hsa04147]
 Exosomal proteins
  Exosomal proteins of breast milk
   10568 (SLC34A2)
SSDB
Motif
Pfam: Na_Pi_cotrans
Other DBs
NCBI-GeneID: 10568
NCBI-ProteinID: NP_006415
OMIM: 604217
HGNC: 11020
Ensembl: ENSG00000157765
UniProt: O95436
LinkDB
Position
4:25655851..25678748
AA seq 690 aa
MAPWPELGDAQPNPDKYLEGAAGQQPTAPDKSKETNKTDNTEAPVTKIELLPSYSTATLI
DEPTEVDDPWNLPTLQDSGIKWSERDTKGKILCFFQGIGRLILLLGFLYFFVCSLDILSS
AFQLVGGKMAGQFFSNSSIMSNPLLGLVIGVLVTVLVQSSSTSTSIVVSMVSSSLLTVRA
AIPIIMGANIGTSITNTIVALMQVGDRSEFRRAFAGATVHDFFNWLSVLVLLPVEVATHY
LEIITQLIVESFHFKNGEDAPDLLKVITKPFTKLIVQLDKKVISQIAMNDEKAKNKSLVK
IWCKTFTNKTQINVTVPSTANCTSPSLCWTDGIQNWTMKNVTYKENIAKCQHIFVNFHLP
DLAVGTILLILSLLVLCGCLIMIVKILGSVLKGQVATVIKKTINTDFPFPFAWLTGYLAI
LVGAGMTFIVQSSSVFTSALTPLIGIGVITIERAYPLTLGSNIGTTTTAILAALASPGNA
LRSSLQIALCHFFFNISGILLWYPIPFTRLPIRMAKGLGNISAKYRWFAVFYLIIFFFLI
PLTVFGLSLAGWRVLVGVGVPVVFIIILVLCLRLLQSRCPRVLPKKLQNWNFLPLWMRSL
KPWDAVVSKFTGCFQMRCCCCCRVCCRACCLLCDCPKCCRCSKCCEDLEEAQEGQDVPVK
APETFDNITISREAQGEVPASDSKTECTAL
NT seq 2073 nt   +upstreamnt  +downstreamnt
atggctccctggcctgaattgggagatgcccagcccaaccccgataagtacctcgaaggg
gccgcaggtcagcagcccactgcccctgataaaagcaaagagaccaacaaaacagataac
actgaggcacctgtaaccaagattgaacttctgccgtcctactccacggctacactgata
gatgagcccactgaggtggatgacccctggaacctacccactcttcaggactcggggatc
aagtggtcagagagagacaccaaagggaagattctctgtttcttccaagggattgggaga
ttgattttacttctcggatttctctactttttcgtgtgctccctggatattcttagtagc
gccttccagctggttggaggaaaaatggcaggacagttcttcagcaacagctctattatg
tccaaccctttgttggggctggtgatcggggtgctggtgaccgtcttggtgcagagctcc
agcacctcaacgtccatcgttgtcagcatggtgtcctcttcattgctcactgttcgggct
gccatccccattatcatgggggccaacattggaacgtcaatcaccaacactattgttgcg
ctcatgcaggtgggagatcggagtgagttcagaagagcttttgcaggagccactgtccat
gacttcttcaactggctgtccgtgttggtgctcttgcccgtggaggtggccacccattac
ctcgagatcataacccagcttatagtggagagcttccacttcaagaatggagaagatgcc
ccagatcttctgaaagtcatcactaagcccttcacaaagctcattgtccagctggataaa
aaagttatcagccaaattgcaatgaacgatgaaaaagcgaaaaacaagagtcttgtcaag
atttggtgcaaaacttttaccaacaagacccagattaacgtcactgttccctcgactgct
aactgcacctccccttccctctgttggacggatggcatccaaaactggaccatgaagaat
gtgacctacaaggagaacatcgccaaatgccagcatatctttgtgaatttccacctcccg
gatcttgctgtgggcaccatcttgctcatactctccctgctggtcctctgtggttgcctg
atcatgattgtcaagatcctgggctctgtgctcaaggggcaggtcgccactgtcatcaag
aagaccatcaacactgatttcccctttccctttgcatggttgactggctacctggccatc
ctcgtcggggcaggcatgaccttcatcgtacagagcagctctgtgttcacgtcggccttg
acccccctgattggaatcggcgtgataaccattgagagggcttatccactcacgctgggc
tccaacatcggcaccaccaccaccgccatcctggccgccttagccagccctggcaatgca
ttgaggagttcactccagatcgccctgtgccactttttcttcaacatctccggcatcttg
ctgtggtacccgatcccgttcactcgcctgcccatccgcatggccaaggggctgggcaac
atctctgccaagtatcgctggttcgccgtcttctacctgatcatcttcttcttcctgatc
ccgctgacggtgtttggcctctcgctggccggctggcgggtgctggttggtgtcggggtt
cccgtcgtcttcatcatcatcctggtactgtgcctccgactcctgcagtctcgctgccca
cgcgtcctgccgaagaaactccagaactggaacttcctgccgctgtggatgcgctcgctg
aagccctgggatgccgtcgtctccaagttcaccggctgcttccagatgcgctgctgctgc
tgctgccgcgtgtgctgccgcgcgtgctgcttgctgtgtgactgccccaagtgctgccgc
tgcagcaagtgctgcgaggacttggaggaggcgcaggaggggcaggatgtccctgtcaag
gctcctgagacctttgataacataaccattagcagagaggctcagggtgaggtccctgcc
tcggactcaaagaccgaatgcacggccttgtag

KEGG   Homo sapiens (human): 142680
Entry
142680            CDS       T01001                                 
Symbol
SLC34A3, HHRH, NPT2C, NPTIIc
Name
(RefSeq) solute carrier family 34 member 3
  KO
K14683  solute carrier family 34 (sodium-dependent phosphate cotransporter)
Organism
hsa  Homo sapiens (human)
Pathway
hsa04928  Parathyroid hormone synthesis, secretion and action
hsa04978  Mineral absorption
Network
nt06325  Hormone/cytokine signaling
  Element
N01824  SGK1-NHERF1+NPT signaling pathway
Disease
H00214  Hypophosphatemic rickets
H02138  Hereditary hypophophatemic rickets with hypercalciuria
Brite
KEGG Orthology (KO) [BR:hsa00001]
 09150 Organismal Systems
  09152 Endocrine system
   04928 Parathyroid hormone synthesis, secretion and action
    142680 (SLC34A3)
  09154 Digestive system
   04978 Mineral absorption
    142680 (SLC34A3)
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   02000 Transporters [BR:hsa02000]
    142680 (SLC34A3)
   04147 Exosome [BR:hsa04147]
    142680 (SLC34A3)
Transporters [BR:hsa02000]
 Solute carrier family (SLC)
  SLC34: Type II Na+-phosphate cotransporter
   142680 (SLC34A3)
Exosome [BR:hsa04147]
 Exosomal proteins
  Exosomal proteins of breast milk
   142680 (SLC34A3)
SSDB
Motif
Pfam: Na_Pi_cotrans
Other DBs
NCBI-GeneID: 142680
NCBI-ProteinID: NP_001170787
OMIM: 609826
HGNC: 20305
Ensembl: ENSG00000198569
UniProt: Q8N130
LinkDB
Position
9:137229730..137236555
AA seq 599 aa
MPSSLPGSQVPHPTLDAVDLVEKTLRNEGTSSSAPVLEEGDTDPWTLPQLKDTSQPWKEL
RVAGRLRRVAGSVLKACGLLGSLYFFICSLDVLSSAFQLLGSKVAGDIFKDNVVLSNPVA
GLVIGVLVTALVQSSSTSSSIVVSMVAAKLLTVRVSVPIIMGVNVGTSITSTLVSMAQSG
DRDEFQRAFSGSAVHGIFNWLTVLVLLPLESATALLERLSELALGAASLTPRAQAPDILK
VLTKPLTHLIVQLDSDMIMSSATGNATNSSLIKHWCGTTGQPTQENSSCGAFGPCTEKNS
TAPADRLPCRHLFAGTELTDLAVGCILLAGSLLVLCGCLVLIVKLLNSVLRGRVAQVVRT
VINADFPFPLGWLGGYLAVLAGAGLTFALQSSSVFTAAVVPLMGVGVISLDRAYPLLLGS
NIGTTTTALLAALASPADRMLSALQVALIHFFFNLAGILLWYLVPALRLPIPLARHFGVV
TARYRWVAGVYLLLGFLLLPLAAFGLSLAGGMELAAVGGPLVGLVLLVILVTVLQRRRPA
WLPVRLRSWAWLPVWLHSLEPWDRLVTRCCPCNVCSPPKATTKEAYCYENPEILASQQL
NT seq 1800 nt   +upstreamnt  +downstreamnt
atgccgagttcccttcccggcagccaggtcccccaccccactctggacgcggttgaccta
gtggaaaagactctgaggaatgaagggacctccagttctgctccagtcttggaggaaggg
gacacagacccctggaccctccctcagctgaaggacacaagccagccctggaaagagctc
cgcgtggccggcaggctgcgccgcgtggccggcagcgtcctcaaggcctgcgggctcctc
ggcagcctgtacttcttcatctgctctctggacgtcctcagctccgccttccagctgctg
ggcagcaaagtggccggagacatcttcaaggacaacgtggtgctgtccaaccctgtggct
ggactggtcattggcgtgctggtcacagccctggtgcagagttccagcacgtcctcctcc
atcgtggtcagcatggtggctgctaagctgctgactgtccgggtgtctgtgcccatcatc
atgggtgtcaacgtaggcacatccatcaccagcaccctggtctcaatggcgcagtcaggg
gaccgggatgaatttcagagggctttcagcggctcggcggtgcacgggatcttcaactgg
ctcacagtgctggtcctgctgccactggagagcgccacggccctgctggagaggctaagt
gagctagccctgggtgccgccagcctgacacccagggcgcaggcgcccgacatcctcaag
gtgctgacgaagccgctcacacacctcatcgtgcagttggactccgacatgatcatgagc
agtgccacaggcaacgccactaacagcagtctcattaagcactggtgcggcaccacgggg
cagccgacccaggagaacagcagctgtggcgccttcggcccgtgcacagagaagaacagc
acagccccggcggacaggctgccctgccgccacctgtttgcgggcacggagctcacggac
ctggccgtgggctgcatcctgctggccggctccctgctggtgctctgcggctgcctggtc
ctcatagtcaagctgctcaactctgtgctgcgcggccgcgtggcccaggtcgtgaggaca
gtcatcaatgcggacttccccttcccgctgggctggctcggcggctacctggccgtcctc
gcgggcgccggcctgaccttcgcactgcagagcagcagcgtcttcacggcggccgtcgtg
cccctcatgggggtcggggtgatcagtctggaccgggcgtaccccctcttactgggctcc
aacatcggcaccactaccacagccctgctggctgccctggccagccccgcagacaggatg
ctcagcgccctgcaggtcgccctcatccacttcttcttcaacctggccggcatcctgctg
tggtacctggtgcctgcactgcggctgcccatcccgctggccaggcacttcggggtggtg
accgcccgttaccgctgggtggctggggtctacctgctgctcggattcctgctgctgccc
ctggcggccttcgggctctccctggcagggggcatggagctggccgctgtcgggggtccc
ctggtggggctggtgctcctcgtcatcctggttactgtcctgcagcggcgccggccggcc
tggctgcctgtccgcctgcgctcctgggcctggctccccgtctggctccattctctggag
ccctgggaccgcctggtgacccgctgctgcccctgcaacgtctgcagccccccgaaggcc
accaccaaagaggcctactgctacgagaaccctgagatcttggcctcccagcagttgtga

KEGG   Homo sapiens (human): 6569
Entry
6569              CDS       T01001                                 
Symbol
SLC34A1, FRTS2, HCINF2, NAPI-3, NPHLOP1, NPT2, NPTIIa, SLC11, SLC17A2
Name
(RefSeq) solute carrier family 34 member 1
  KO
K14683  solute carrier family 34 (sodium-dependent phosphate cotransporter)
Organism
hsa  Homo sapiens (human)
Pathway
hsa04928  Parathyroid hormone synthesis, secretion and action
hsa04978  Mineral absorption
Network
nt06325  Hormone/cytokine signaling
  Element
N01824  SGK1-NHERF1+NPT signaling pathway
Disease
H00888  Nephrolithiasis/osteoporosis, hypophosphatemic
H01198  Fanconi renotubular syndrome
H01371  Hypercalcemia infantile
Brite
KEGG Orthology (KO) [BR:hsa00001]
 09150 Organismal Systems
  09152 Endocrine system
   04928 Parathyroid hormone synthesis, secretion and action
    6569 (SLC34A1)
  09154 Digestive system
   04978 Mineral absorption
    6569 (SLC34A1)
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   02000 Transporters [BR:hsa02000]
    6569 (SLC34A1)
   04147 Exosome [BR:hsa04147]
    6569 (SLC34A1)
Transporters [BR:hsa02000]
 Solute carrier family (SLC)
  SLC34: Type II Na+-phosphate cotransporter
   6569 (SLC34A1)
Exosome [BR:hsa04147]
 Exosomal proteins
  Exosomal proteins of breast milk
   6569 (SLC34A1)
SSDB
Motif
Pfam: Na_Pi_cotrans
Other DBs
NCBI-GeneID: 6569
NCBI-ProteinID: NP_003043
OMIM: 182309
HGNC: 11019
Ensembl: ENSG00000131183
UniProt: Q06495 Q7Z725 Q86VN6
LinkDB
Position
5:177384434..177398848
AA seq 639 aa
MLSYGERLGSPAVSPLPVRGGHVMRGTAFAYVPSPQVLHRIPGTSAYAFPSLGPVALAEH
TCPCGEVLERHEPLPAKLALEEEQKPESRLVPKLRQAGAMLLKVPLMLTFLYLFVCSLDM
LSSAFQLAGGKVAGDIFKDNAILSNPVAGLVVGILVTVLVQSSSTSTSIIVSMVSSGLLE
VSSAIPIIMGSNIGTSVTNTIVALMQAGDRTDFRRAFAGATVHDCFNWLSVLVLLPLEAA
TGYLHHITRLVVASFNIHGGRDAPDLLKIITEPFTKLIIQLDESVITSIATGDESLRNHS
LIQIWCHPDSLQAPTSMSRAEANSSQTLGNATMEKCNHIFVDTGLPDLAVGLILLAGSLV
LLCTCLILLVKMLNSLLKGQVAKVIQKVINTDFPAPFTWVTGYFAMVVGASMTFVVQSSS
VFTSAITPLIGLGVISIERAYPLTLGSNIGTTTTAILAALASPREKLSSAFQIALCHFFF
NISGILLWYPVPCTRLPIRMAKALGKRTAKYRWFAVLYLLVCFLLLPSLVFGISMAGWQV
MVGVGTPFGALLAFVVLINVLQSRSPGHLPKWLQTWDFLPRWMHSLKPLDHLITRATLCC
ARPEPRSPPLPPRVFLEELPPATPSPRLALPAHHNATRL
NT seq 1920 nt   +upstreamnt  +downstreamnt
atgttgtcctacggagagaggctggggtcccctgctgtctccccactcccagtccgtggg
gggcatgtgatgcgagggacggcctttgcctacgtgcccagccctcaggtcctacacagg
atcccggggacctctgcctatgccttccccagcctgggccctgtggcccttgctgagcac
acctgcccctgtggggaggtcctggagcgccatgaaccactgcctgccaagctggccctg
gaggaggagcagaagccagagtccaggctggtccccaagctgcgccaggctggcgccatg
ctgctcaaggtgccactgatgctcaccttcctctacctcttcgtctgctccctggacatg
ctcagctcggccttccagctggctggagggaaggtggctggtgacatcttcaaggataac
gccatcctgtccaacccggtggccgggctggtggtggggatcctggtgaccgtgctggtg
cagagctccagcacctccacatccatcatcgtcagcatggtctcctctggcttgctggag
gtgagctctgccatccccatcatcatgggctccaacatcggcacctctgtcaccaacacc
atcgtggccctgatgcaggcgggggacaggactgacttccggcgggccttcgcgggggcc
acggtgcatgactgctttaactggctgtcagtgctggtcctgctgcccctggaggctgcc
actggctacctgcaccacatcactcgacttgtggtggcctccttcaacatccatggtggc
cgtgatgctcctgacctgctcaagatcatcacagagcccttcacgaagctcatcatccag
ctggacgagtctgtgataaccagcattgccactggtgatgagtccctgaggaaccacagt
ctcatccagatctggtgccacccagactccttacaggctcccacctccatgtccagagca
gaggccaactccagccagacccttggaaatgccaccatggagaaatgcaaccacatcttt
gtggacactggcctaccggacctggctgtggggctcatcctgctggcaggatccctggtg
ctgctgtgcacctgcctcatcctcctagtcaagatgctcaactccctgctcaagggccaa
gtggccaaggtcatccagaaggtcatcaatacggacttccctgcccccttcacctgggtc
acaggctactttgccatggtggtgggcgccagcatgaccttcgtggtccagagcagttct
gtgttcacctcggccatcaccccactcatcggtcttggtgtgatcagcattgagagggcc
tacccgctcacactgggttccaacatcggcaccaccaccacggccatcctggctgccctg
gccagccccagggagaagctgtccagcgctttccagattgccctctgtcacttcttcttc
aacatctcgggtatccttctgtggtacccggtgccctgcacacgcctgcccatccgcatg
gccaaggcgctggggaaacgcacggccaagtaccgctggtttgccgtcctctatctcctt
gtctgcttcctgctgctgccctcactggtgtttggcatctccatggcaggctggcaggtc
atggtaggtgtgggcacgcccttcggggccctgctggccttcgtggtgctcatcaatgtc
ctgcagagtcggagtcccgggcacctgcccaagtggttacagacatgggacttcctgcct
cgctggatgcactccctgaagcccctggaccacctcatcacccgcgccaccctatgctgt
gccaggcctgagccccgctcacccccgctgccccccagggtcttcctggaggagctaccc
cctgccacaccctccccccgtcttgcactgcctgctcaccacaatgccacccgcctctag

KEGG   DISEASE: Hypophosphatemic rickets
Entry
H00214                      Disease                                
Name
Hypophosphatemic rickets
  Subgroup
X-linked dominant hypophosphatemic rickets (XLH) [DS:H02143]
X-linked recessive hypophosphatemic rickets (XLRH) [DS:H02142]
Autosomal dominant hypophosphatemic rickets (ADHR) [DS:H02141]
Autosomal recessive hypophosphatemic rickets (ARHR) [DS:H02139]
Hereditary hypophophatemic rickets with hypercalciuria (HHRH) [DS:H02138]
Description
Hypophosphataemic rickets, also known as vitamin D resistant rickets, is a group of genetic disorders characterized by defective reabsorption of inorganic phosphorus by the renal tubules resulting in hypophosphatemia and rickets associated with mineralization defect. Fibroblast growth factor-23 (FGF23) regulates phosphate reabsorption in the kidney and therefore plays an essential role in phosphate balance in humans. There is a host of defects that ultimately lead to excess FGF23 levels and thereby cause renal phosphate wasting and hypophosphatemic rickets.
Category
Inherited metabolic disorder
Brite
Human diseases in ICD-11 classification [BR:br08403]
 05 Endocrine, nutritional or metabolic diseases
  Metabolic disorders
   Disorders of metabolite absorption or transport
    5C63  Disorders of vitamin or non-protein cofactor absorption or transport
     H00214  Hypophosphatemic rickets
Pathway-based classification of diseases [BR:br08402]
 Endocrine system
  nt06325  Hormone/cytokine signaling
   H00214  Hypophosphatemic rickets
Pathway
hsa04928  Parathyroid hormone synthesis, secretion and action
Network
nt06325 Hormone/cytokine signaling
Gene
(XLHR) PHEX [HSA:5251] [KO:K08636]
(XLRH) CLCN5 [HSA:1184] [KO:K05012]
(ADHR) FGF23 [HSA:8074] [KO:K22428]
(ARHR1) DMP1 [HSA:1758] [KO:K23328]
(ARHR2) ENPP1 [HSA:5167] [KO:K01513]
(HHRH) SLC34A3 [HSA:142680] [KO:K14683]
Other DBs
ICD-11: 5C63.22
MeSH: D063730 D053098
OMIM: 307800 300554 193100 241520 613312 241530
Reference
  Authors
Pettifor JM
  Title
What's new in hypophosphataemic rickets?
  Journal
Eur J Pediatr 167:493-9 (2008)
DOI:10.1007/s00431-007-0662-1
Reference
  Authors
de Menezes Filho H, de Castro LC, Damiani D
  Title
Hypophosphatemic rickets and osteomalacia.
  Journal
Arq Bras Endocrinol Metabol 50:802-13 (2006)
DOI:10.1590/S0004-27302006000400025
Reference
PMID:7550339 (PHEX)
  Title
A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium.
  Journal
Nat Genet 11:130-6 (1995)
DOI:10.1038/ng1095-130
Reference
PMID:8559248 (CLCN5)
  Authors
Lloyd SE, Pearce SH, Fisher SE, Steinmeyer K, Schwappach B, Scheinman SJ, Harding B, Bolino A, Devoto M, Goodyer P, Rigden SP, Wrong O, Jentsch TJ, Craig IW, Thakker RV
  Title
A common molecular basis for three inherited kidney stone diseases.
  Journal
Nature 379:445-9 (1996)
DOI:10.1038/379445a0
Reference
PMID:11062477 (FGF23)
  Title
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.
  Journal
Nat Genet 26:345-8 (2000)
DOI:10.1038/81664
Reference
PMID:17033625 (DMP1)
  Authors
Lorenz-Depiereux B, Bastepe M, Benet-Pages A, Amyere M, Wagenstaller J, Muller-Barth U, Badenhoop K, Kaiser SM, Rittmaster RS, Shlossberg AH, Olivares JL, Loris C, Ramos FJ, Glorieux F, Vikkula M, Juppner H, Strom TM
  Title
DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis.
  Journal
Nat Genet 38:1248-50 (2006)
DOI:10.1038/ng1868
Reference
PMID:20137772 (ENPP1)
  Authors
Levy-Litan V, Hershkovitz E, Avizov L, Leventhal N, Bercovich D, Chalifa-Caspi V, Manor E, Buriakovsky S, Hadad Y, Goding J, Parvari R
  Title
Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene.
  Journal
Am J Hum Genet 86:273-8 (2010)
DOI:10.1016/j.ajhg.2010.01.010
Reference
PMID:16358215 (SLC34A3)
  Authors
Lorenz-Depiereux B, Benet-Pages A, Eckstein G, Tenenbaum-Rakover Y, Wagenstaller J, Tiosano D, Gershoni-Baruch R, Albers N, Lichtner P, Schnabel D, Hochberg Z, Strom TM
  Title
Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3.
  Journal
Am J Hum Genet 78:193-201 (2006)
DOI:10.1086/499410
LinkDB

» Japanese version

KEGG   DISEASE: Nephrolithiasis/osteoporosis, hypophosphatemic
Entry
H00888                      Disease                                
Name
Nephrolithiasis/osteoporosis, hypophosphatemic
Description
Nephrolithiasis/osteoporosis, hypophosphatemic (NPHLOP) is a genetically heterologous group of disorders characterized by the formation of renal calcium stones or bone demineralization due to impaired renal phosphate reabsorption. It is caused by either mutations in SLC34A1, a sodium-phosphate cotransporter expressed in kidney and polarized osteoclasts, or in sodium-hydrogen exchanger regulatory factor (NHERF)1, that controls renal phosphate transport by trafficking SLC34A1.
Category
Urinary system disease
Brite
Human diseases in ICD-11 classification [BR:br08403]
 16 Diseases of the genitourinary system
  Diseases of the urinary system
   GB90  Certain specified disorders of kidney or ureter
    H00888  Nephrolithiasis/osteoporosis, hypophosphatemic
Pathway-based classification of diseases [BR:br08402]
 Endocrine system
  nt06325  Hormone/cytokine signaling
   H00888  Nephrolithiasis/osteoporosis, hypophosphatemic
Pathway
hsa04928 Parathyroid hormone synthesis, secretion and action   
Network
nt06325 Hormone/cytokine signaling
Gene
(NPHLOP1) SLC34A1 [HSA:6569] [KO:K14683]
(NPHLOP2) NHERF1 [HSA:9368] [KO:K13365]
Other DBs
ICD-11: GB90.48
MeSH: C567363 C567362
OMIM: 612286 612287
Reference
  Authors
Alizadeh Naderi AS, Reilly RF
  Title
Hereditary disorders of renal phosphate wasting.
  Journal
Nat Rev Nephrol 6:657-65 (2010)
DOI:10.1038/nrneph.2010.121
Reference
  Authors
Prie D, Beck L, Friedlander G, Silve C
  Title
Sodium-phosphate cotransporters, nephrolithiasis and bone demineralization.
  Journal
Curr Opin Nephrol Hypertens 13:675-81 (2004)
DOI:10.1097/00041552-200411000-00015
Reference
PMID:12324554 (SLC34A1)
  Authors
Prie D, Huart V, Bakouh N, Planelles G, Dellis O, Gerard B, Hulin P, Benque-Blanchet F, Silve C, Grandchamp B, Friedlander G
  Title
Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter.
  Journal
N Engl J Med 347:983-91 (2002)
DOI:10.1056/NEJMoa020028
Reference
PMID:18784102 (NHERF1)
  Authors
Karim Z, Gerard B, Bakouh N, Alili R, Leroy C, Beck L, Silve C, Planelles G, Urena-Torres P, Grandchamp B, Friedlander G, Prie D
  Title
NHERF1 mutations and responsiveness of renal parathyroid hormone.
  Journal
N Engl J Med 359:1128-35 (2008)
DOI:10.1056/NEJMoa0802836
LinkDB

» Japanese version

KEGG   DISEASE: Fanconi renotubular syndrome
Entry
H01198                      Disease                                
Name
Fanconi renotubular syndrome
Description
Fanconi renotubular syndrome (FRTS) is a disease resulting from a generalized dysfunction of the proximal kidney tubule leading to decreased solute and water reabsorption. Patients had a generalized proximal tubulopathy, renal phosphate wasting, bone mineral deficiency, and decreased glomerular filtration rates. It is reported that mutations in SLC34A1, which encodes the renal sodium-inorganic phosphate cotransporter NaPi-IIa, may cause this disease.
Category
Inherited metabolic disorder
Brite
Human diseases in ICD-11 classification [BR:br08403]
 16 Diseases of the genitourinary system
  Diseases of the urinary system
   GB90  Certain specified disorders of kidney or ureter
    H01198  Fanconi renotubular syndrome
Pathway-based classification of diseases [BR:br08402]
 Endocrine system
  nt06325  Hormone/cytokine signaling
   H01198  Fanconi renotubular syndrome
Pathway
hsa04928  Parathyroid hormone synthesis, secretion and action
Network
nt06325 Hormone/cytokine signaling
Gene
(FRTS1) GATM [HSA:2628] [KO:K00613]
(FRTS2) SLC34A1 [HSA:6569] [KO:K14683]
(FRTS3) EHHADH [HSA:1962] [KO:K07514]
(FRTS4) HNF4A [HSA:3172] [KO:K07292]
(FRTS5) NDUFAF6 [HSA:137682] [KO:K18163]
Other DBs
ICD-11: GB90.42
MeSH: D005198
OMIM: 134600 613388 615605 616026 618913
Reference
PMID:29654216 (FRTS1)
  Authors
Reichold M, Klootwijk ED, Reinders J, Otto EA, Milani M, Broeker C, Laing C, Wiesner J, Devi S, Zhou W, Schmitt R, Tegtmeier I, Sterner C, Doellerer H, Renner K, Oefner PJ, Dettmer K, Simbuerger JM, Witzgall R, Stanescu HC, Dumitriu S, Iancu D, Patel V, Mozere M, Tekman M, Jaureguiberry G, Issler N, Kesselheim A, Walsh SB, Gale DP, Howie AJ, Martins JR, Hall AM, Kasgharian M, O'Brien K, Ferreira CR, Atwal PS, Jain M, Hammers A, Charles-Edwards G, Choe CU, Isbrandt D, Cebrian-Serrano A, Davies B, Sandford RN, Pugh C, Konecki DS, Povey S, Bockenhauer D, Lichter-Konecki U, Gahl WA, Unwin RJ, Warth R, Kleta R
  Title
Glycine Amidinotransferase (GATM), Renal Fanconi Syndrome, and Kidney Failure.
  Journal
J Am Soc Nephrol 29:1849-1858 (2018)
DOI:10.1681/ASN.2017111179
Reference
PMID:20335586 (FRTS2)
  Authors
Magen D, Berger L, Coady MJ, Ilivitzki A, Militianu D, Tieder M, Selig S, Lapointe JY, Zelikovic I, Skorecki K
  Title
A loss-of-function mutation in NaPi-IIa and renal Fanconi's syndrome.
  Journal
N Engl J Med 362:1102-9 (2010)
DOI:10.1056/NEJMoa0905647
Reference
PMID:24401050 (FRTS3)
  Authors
Klootwijk ED, Reichold M, Helip-Wooley A, Tolaymat A, Broeker C, Robinette SL, Reinders J, Peindl D, Renner K, Eberhart K, Assmann N, Oefner PJ, Dettmer K, Sterner C, Schroeder J, Zorger N, Witzgall R, Reinhold SW, Stanescu HC, Bockenhauer D, Jaureguiberry G, Courtneidge H, Hall AM, Wijeyesekera AD, Holmes E, Nicholson JK, O'Brien K, Bernardini I, Krasnewich DM, Arcos-Burgos M, Izumi Y, Nonoguchi H, Jia Y, Reddy JK, Ilyas M, Unwin RJ, Gahl WA, Warth R, Kleta R
  Title
Mistargeting of peroxisomal EHHADH and inherited renal Fanconi's syndrome.
  Journal
N Engl J Med 370:129-38 (2014)
DOI:10.1056/NEJMoa1307581
Reference
PMID:24285859 (FRTS4)
  Authors
Hamilton AJ, Bingham C, McDonald TJ, Cook PR, Caswell RC, Weedon MN, Oram RA, Shields BM, Shepherd M, Inward CD, Hamilton-Shield JP, Kohlhase J, Ellard S, Hattersley AT
  Title
The HNF4A R76W mutation causes atypical dominant Fanconi syndrome in addition to a beta cell phenotype.
  Journal
J Med Genet 51:165-9 (2014)
DOI:10.1136/jmedgenet-2013-102066
Reference
PMID:27466185 (FRTS5)
  Authors
Hartmannova H, Piherova L, Tauchmannova K, Kidd K, Acott PD, Crocker JF, Oussedik Y, Mallet M, Hodanova K, Stranecky V, Pristoupilova A, Baresova V, Jedlickova I, Zivna M, Sovova J, Hulkova H, Robins V, Vrbacky M, Pecina P, Kaplanova V, Houstek J, Mracek T, Thibeault Y, Bleyer AJ, Kmoch S
  Title
Acadian variant of Fanconi syndrome is caused by mitochondrial respiratory chain complex I deficiency due to a non-coding mutation in complex I assembly factor NDUFAF6.
  Journal
Hum Mol Genet 25:4062-4079 (2016)
DOI:10.1093/hmg/ddw245
LinkDB

» Japanese version

KEGG   DISEASE: Pulmonary alveolar microlithiasis
Entry
H01298                      Disease                                
Name
Pulmonary alveolar microlithiasis
Description
Pulmonary alveolar microlithiasis (PALM) is a rare disease characterized by the deposition of calcium phosphate microliths throughout the lungs. Most patients are asymptomatic for several years, and cases with early onset or rapid progression are rare. One-third of the reported cases are familial. It has been suggested that mutations in SLC34A2 cause this disease.
Category
Respiratory system disease
Brite
Human diseases in ICD-11 classification [BR:br08403]
 12 Diseases of the respiratory system
  Respiratory diseases principally affecting the lung interstitium
   CB06  Pulmonary alveolar microlithiasis
    H01298  Pulmonary alveolar microlithiasis
Gene
SLC34A2 [HSA:10568] [KO:K14683]
Other DBs
ICD-11: CB06
OMIM: 265100
Reference
  Authors
Corut A, Senyigit A, Ugur SA, Altin S, Ozcelik U, Calisir H, Yildirim Z, Gocmen A, Tolun A
  Title
Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis.
  Journal
Am J Hum Genet 79:650-6 (2006)
DOI:10.1086/508263
LinkDB

» Japanese version

KEGG   DISEASE: Hypercalcemia infantile
Entry
H01371                      Disease                                
Name
Hypercalcemia infantile;
Idiopathic infantile hypercalcemia
Description
Idiopathic infantile hypercalcemia is autosomal recessive disorder that is characterized by severe hypercalcemia, failure to thrive, vomiting, dehydration, and nephrocalcinosis. It has been reported that mutations in the vitamin D-metabolizing enzyme CYP24A1 cause this disease. The presence of CYP24A1 mutations explains the increased sensitivity to vitamin D in patients with idiopathic infantile hypercalcemia.
Category
Inherited metabolic disorder
Brite
Human diseases in ICD-11 classification [BR:br08403]
 05 Endocrine, nutritional or metabolic diseases
  Metabolic disorders
   Disorders of metabolite absorption or transport
    5C64  Disorders of mineral absorption or transport
     H01371  Hypercalcemia infantile
Pathway-based classification of diseases [BR:br08402]
 Endocrine system
  nt06325  Hormone/cytokine signaling
   H01371  Hypercalcemia infantile
Pathway
hsa00100  Steroid biosynthesis
hsa04928  Parathyroid hormone synthesis, secretion and action
Network
nt06325 Hormone/cytokine signaling
Gene
(HCINF1) CYP24A1 [HSA:1591] [KO:K07436]
(HCINF2) SLC34A1 [HSA:6569] [KO:K14683]
Other DBs
ICD-11: 5C64.5
MeSH: C562999
OMIM: 143880 616963
Reference
PMID:21675912 (CYP24A1)
  Authors
Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, John U, Misselwitz J, Klaus G, Kuwertz-Broking E, Fehrenbach H, Wingen AM, Guran T, Hoenderop JG, Bindels RJ, Prosser DE, Jones G, Konrad M
  Title
Mutations in CYP24A1 and idiopathic infantile hypercalcemia.
  Journal
N Engl J Med 365:410-21 (2011)
DOI:10.1056/NEJMoa1103864
Reference
PMID:26047794 (SLC34A1)
  Authors
Schlingmann KP, Ruminska J, Kaufmann M, Dursun I, Patti M, Kranz B, Pronicka E, Ciara E, Akcay T, Bulus D, Cornelissen EA, Gawlik A, Sikora P, Patzer L, Galiano M, Boyadzhiev V, Dumic M, Vivante A, Kleta R, Dekel B, Levtchenko E, Bindels RJ, Rust S, Forster IC, Hernando N, Jones G, Wagner CA, Konrad M
  Title
Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia.
  Journal
J Am Soc Nephrol 27:604-14 (2016)
DOI:10.1681/ASN.2014101025
LinkDB

» Japanese version

KEGG   DISEASE: Hereditary hypophophatemic rickets with hypercalciuria
Entry
H02138                      Disease                                
Name
Hereditary hypophophatemic rickets with hypercalciuria
  Supergrp
Hypophosphatemic rickets [DS:H00214]
Description
Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) is a rare autosomal recessive disorder that is characterized by reduced renal phosphate reabsorption, hypophosphatemia, and rickets. Patients present with hypercalciuria due to increased serum 1, 25-dihydroxyvitamin D levels and increased intestinal calcium absorption. HHRH is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3.
Category
Inherited metabolic disorder
Brite
Human diseases in ICD-11 classification [BR:br08403]
 05 Endocrine, nutritional or metabolic diseases
  Metabolic disorders
   Disorders of metabolite absorption or transport
    5C64  Disorders of mineral absorption or transport
     H02138  Hereditary hypophophatemic rickets with hypercalciuria
Pathway
hsa04928  Parathyroid hormone synthesis, secretion and action
hsa04978  Mineral absorption
Gene
SLC34A3 [HSA:142680] [KO:K14683]
Other DBs
ICD-11: 5C64.3
MeSH: C562793
OMIM: 241530
Reference
  Authors
Bergwitz C, Roslin NM, Tieder M, Loredo-Osti JC, Bastepe M, Abu-Zahra H, Frappier D, Burkett K, Carpenter TO, Anderson D, Garabedian M, Sermet I, Fujiwara TM, Morgan K, Tenenhouse HS, Juppner H
  Title
SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis.
  Journal
Am J Hum Genet 78:179-92 (2006)
DOI:10.1086/499409
Reference
  Authors
Lorenz-Depiereux B, Benet-Pages A, Eckstein G, Tenenbaum-Rakover Y, Wagenstaller J, Tiosano D, Gershoni-Baruch R, Albers N, Lichtner P, Schnabel D, Hochberg Z, Strom TM
  Title
Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3.
  Journal
Am J Hum Genet 78:193-201 (2006)
DOI:10.1086/499410
LinkDB

» Japanese version

KEGG   DRUG: Lifastuzumab
Entry
D11237                      Drug                                   
Name
Lifastuzumab (USAN)
Formula
C6504H10028N1744O2018S46
Exact mass
146324.2835
Mol weight
146414.77
Sequence
(Heavy chain)
EVQLVESGGG LVQPGGSLRL SCAASGFSFS DFAMSWVRQA PGKGLEWVAT IGRVAFHTYY
PDSMKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCARHR GFDVGHFDFW GQGTLVTVSS
ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKKVEP KSCDKTHTCP PCPAPELLGG
PSVFLFPPKP KDTLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYN
STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSREE
MTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW
QQGNVFSCSV MHEALHNHYT QKSLSLSPG
(Light chain)
DIQMTQSPSS LSASVGDRVT ITCRSSETLV HSSGNTYLEW YQQKPGKAPK LLIYRVSNRF
SGVPSRFSGS GSGTDFTLTI SSLQPEDFAT YYCFQGSFNP LTFGQGTKVE IKRTVAAPSV
FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
(Disulfide bridge: H22-H96, H147-H203, H223-L219, H229-H'229, H232-H'232, H264-H324, H370-H428, H'22-H'96, H'147-H'203, H'223-L'219, H'264-H'324, H'370-H'428, L23-L93, L139-L199, L'23-L'93, L'139-L'199)
  Type
Peptide
Efficacy
Antineoplastic, Anti-NaPi-IIb antibody
  Type
Monoclonal antibody
Target
SLC34A2 [HSA:10568] [KO:K14683]
  Pathway
hsa04928  Parathyroid hormone synthesis, secretion and action
hsa04978  Mineral absorption
Brite
Target-based classification of drugs [BR:br08310]
 Transporters
  Solute carrier family
   SLC34
    SLC34A2
     D11237  Lifastuzumab (USAN)
Other DBs
CAS: 1615697-16-9
PubChem: 384585215
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system